PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 4-aminopyridine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

44 hits

Bibliografisk träff 2012-11-13

Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.

Fernandez O, Berger T, Hartung HP, Putzki N.

Expert Rev Clin Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1586/ecp.12.59

Bibliografisk träff 2012-10-16

Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.

Krishnan AV, Kiernan MC.

Mult Scler · research support, non-u.s. gov't; review; journal article · DOI 10.1177/1352458512463769

Bibliografisk träff 2012-08-30

Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.

Schmidt S.

Mult Scler · letter; case reports · DOI 10.1177/1352458512458554

Bibliografisk träff 2012-06-18

Clinical overview of the seizure risk of dalfampridine.

Haut SR, Bienen EJ, Miller A.

Expert Opin Drug Saf · review; journal article · DOI 10.1517/14740338.2012.697896

Bibliografisk träff 2012-04-11

The safety profile of dalfampridine extended release in multiple sclerosis clinical trials.

Cornblath DR, Bienen EJ, Blight AR.

Clin Ther · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.clinthera.2012.03.007

Bibliografisk träff 2011-12-01

Dalfampridine: a new agent for symptomatic management of multiple sclerosis.

McDonald S, Clements JN.

Am J Health Syst Pharm · review; journal article · DOI 10.2146/ajhp110134

Bibliografisk träff 2011-11-23

Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis.

Coleman CI, Sobieraj DM, Marinucci LN.

Curr Med Res Opin · research support, non-u.s. gov't; evaluation study; journal article · DOI 10.1185/03007995.2011.639752

Bibliografisk träff 2011-09-19

A stability indicating simultaneous dual wavelength UV-HPLC method for the determination of potential impurities in fampridine active pharmaceutical ingredient.

Thomas S, Shandilya S, Bharti A, Agarwal A.

J Pharm Biomed Anal · journal article · DOI 10.1016/j.jpba.2011.09.009

Bibliografisk träff 2011-04-28

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis.

Hayes KC.

Neuropsychiatr Dis Treat · review-article; journal article · DOI 10.2147/ndt.s10469

Bibliografisk träff 2011-03-01

Treatment of walking impairment in multiple sclerosis with dalfampridine.

Blight AR.

Ther Adv Neurol Disord · review-article; journal article · DOI 10.1177/1756285611403960

Bibliografisk träff 2010-09-01

Dalfampridine in multiple sclerosis.

Goodman AD, Hyland M.

Drugs Today (Barc) · review; journal article · DOI 10.1358/dot.2010.46.9.1499027

Bibliografisk träff 2010-06-01

Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.

Graudins A, Wong KK.

J Med Toxicol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s13181-010-0073-y

Bibliografisk träff 2010-02-01

[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis].

Husseini L, Leussink VI, Kieseier BC, Hartung HP.

Nervenarzt · review; journal article; english abstract · DOI 10.1007/s00115-009-2902-2

Bibliografisk träff 2009-12-31

Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure.

Gao L, Li Y, Schultz HD, Wang WZ, Wang W, Finch M, Smith LM, Zucker IH.

Am J Physiol Heart Circ Physiol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1152/ajpheart.00145.2009

Bibliografisk träff 2009-12-04

Single-Dose pharmacokinetics of sustained-release fampridine (Fampridine-SR) in healthy volunteers and adults with renal impairment.

Smith W, Swan S, Marbury T, Henney H.

J Clin Pharmacol · clinical trial, phase ii; multicenter study; clinical trial, phase i; journal article · DOI 10.1177/0091270009344857

Bibliografisk träff 2009-10-08

Apamin reduces neuromuscular transmission by activating inhibitory muscarinic M(2) receptors on motor nerve terminals.

de Matos Silva LF, de Paula Ramos ER, Ambiel CR, Correia-de-Sá P, Alves-Do-Prado W.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2009.09.064

Bibliografisk träff 2009-09-01

Impaired voltage gated potassium channel responses in a fetal lamb model of persistent pulmonary hypertension of the newborn.

Konduri GG, Bakhutashvili I, Eis A, Gauthier KM.

Pediatr Res · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1203/pdr.0b013e3181b1bc89

Bibliografisk träff 2009-09-01

Effects of 4-Aminopyridine on Cloned hERG Channels Expressed in Mammalian Cells.

Renganathan M, Sidach S, Blight AR.

Arch Drug Inf · research-article; journal article · DOI 10.1111/j.1753-5174.2009.00021.x

Bibliografisk träff 2009-05-13

Severe accidental overdose of 4-aminopyridine due to a compounding pharmacy error.

Schwam E.

J Emerg Med · journal article; case reports · DOI 10.1016/j.jemermed.2009.04.037

Bibliografisk träff 2009-02-01

Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.

Blight AR, Henney HR.

Clin Ther · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.clinthera.2009.02.004

Bibliografisk träff 2008-04-03

Functional and molecular identification of pH-sensitive K+ channels in murine urinary bladder smooth muscle.

Beckett EA, Han I, Baker SA, Han J, Britton FC, Koh SD.

BJU Int · journal article; research support, n.i.h., extramural · DOI 10.1111/j.1464-410x.2008.07541.x

Bibliografisk träff 2007-07-12

4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury.

McBride JM, Smith DT, Byrn SR, Borgens RB, Shi R.

Neuroscience · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuroscience.2007.05.039

Bibliografisk träff 2006-10-27

H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle.

Rogers PA, Chilian WM, Bratz IN, Bryan RM, Dick GM.

Am J Physiol Heart Circ Physiol · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1152/ajpheart.00696.2006

Bibliografisk träff 2006-10-02

Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell.

Zhanping W, Xiaoyu P, Na C, Shenglan W, Bo W.

Gynecol Oncol · journal article · DOI 10.1016/j.ygyno.2006.08.033

Bibliografisk träff 2006-06-27

4-aminopyridine, a Kv channel antagonist, prevents apoptosis of rat cerebellar granule neurons.

Hu CL, Liu Z, Zeng XM, Liu ZQ, Chen XH, Zhang ZH, Mei YA.

Neuropharmacology · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2006.05.013

Bibliografisk träff 2006-02-01

An unusual case of 4-aminopyridine toxicity.

Johnson NC, Morgan MW.

J Emerg Med · journal article; case reports · DOI 10.1016/j.jemermed.2005.04.020

Bibliografisk träff 2006-01-01

Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro.

Peña F, Alavez-Pérez N.

Epilepsia · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1528-1167.2006.00369.x

Bibliografisk träff 2005-10-14

In ovo neuromuscular stimulation alters the skeletal muscle phenotype of the chick.

Heywood JL, McEntee GM, Stickland NC.

J Muscle Res Cell Motil · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s10974-005-9007-8

Bibliografisk träff 2005-03-01

Effects of statins on vascular function of endothelin-1.

Mraiche F, Cena J, Das D, Vollrath B.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0706114

Bibliografisk träff 2004-01-01

Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury.

Hayes KC, Potter PJ, Hsieh JT, Katz MA, Blight AR, Cohen R.

Arch Phys Med Rehabil · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/s0003-9993(03)00651-8